bucladesine has been researched along with Leiomyoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, M; Kasai, T; Murakami, K; Segawa, T; Shozu, M; Sumitani, H; Yang, HJ | 1 |
1 other study(ies) available for bucladesine and Leiomyoma
Article | Year |
---|---|
Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
Topics: Adult; Aromatase; Bucladesine; Dexamethasone; Dinoprostone; Drug Combinations; Enzyme Induction; Female; Gene Expression Regulation; Gene Library; Glucocorticoids; Humans; Interleukin-1; Leiomyoma; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 2002 |